BNP Paribas Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Buy
31,402
+15,569
+98% +$5.07M 0.03% 456
2025
Q1
$4.29M Buy
15,833
+3,784
+31% +$1.02M 0.01% 575
2024
Q4
$2.84M Buy
12,049
+6,678
+124% +$1.57M 0.01% 656
2024
Q3
$1.48M Sell
5,371
-703
-12% -$193K ﹤0.01% 712
2024
Q2
$1.48M Sell
6,074
-556
-8% -$135K ﹤0.01% 722
2024
Q1
$991K Sell
6,630
-118,749
-95% -$17.7M ﹤0.01% 745
2023
Q4
$24M Buy
125,379
+12,249
+11% +$2.34M 0.07% 275
2023
Q3
$20M Buy
113,130
+11,588
+11% +$2.05M 0.06% 290
2023
Q2
$19.3M Sell
101,542
-13,353
-12% -$2.54M 0.06% 293
2023
Q1
$23M Sell
114,895
-11,952
-9% -$2.39M 0.08% 264
2022
Q4
$30.1M Buy
126,847
+61,583
+94% +$14.6M 0.11% 220
2022
Q3
$13.1M Buy
65,264
+11,893
+22% +$2.38M 0.05% 370
2022
Q2
$7.78M Buy
53,371
+8,992
+20% +$1.31M 0.03% 445
2022
Q1
$7.25M Buy
44,379
+43,121
+3,428% +$7.04M 0.03% 471
2021
Q4
$213K Sell
1,258
-56,992
-98% -$9.65M ﹤0.01% 898
2021
Q3
$11M Buy
58,250
+6,595
+13% +$1.25M 0.04% 397
2021
Q2
$8.76M Sell
51,655
-24,006
-32% -$4.07M 0.03% 456
2021
Q1
$10.7M Buy
75,661
+14,714
+24% +$2.08M 0.04% 402
2020
Q4
$7.92M Buy
60,947
+10,087
+20% +$1.31M 0.04% 417
2020
Q3
$7.41M Buy
50,860
+2,797
+6% +$407K 0.04% 372
2020
Q2
$7.12M Sell
48,063
-6,315
-12% -$935K 0.05% 365
2020
Q1
$5.92M Buy
+54,378
New +$5.92M 0.05% 358
2019
Q4
Sell
-2,502
Closed -$201K 823
2019
Q3
$201K Buy
+2,502
New +$201K ﹤0.01% 837
2016
Q4
Sell
-3,133
Closed -$212K 980
2016
Q3
$212K Buy
+3,133
New +$212K ﹤0.01% 1064
2016
Q1
Sell
-25,094
Closed -$2.36M 1067
2015
Q4
$2.36M Buy
25,094
+1,939
+8% +$183K 0.02% 629
2015
Q3
$1.86M Sell
23,155
-24,465
-51% -$1.97M 0.02% 692
2015
Q2
$5.71M Sell
47,620
-20,510
-30% -$2.46M 0.05% 464
2015
Q1
$7.11M Sell
68,130
-100,598
-60% -$10.5M 0.05% 390
2014
Q4
$16.4M Sell
168,728
-50,856
-23% -$4.93M 0.13% 208
2014
Q3
$17.2M Buy
219,584
+19,145
+10% +$1.5M 0.14% 195
2014
Q2
$12.7M Buy
200,439
+61,479
+44% +$3.88M 0.1% 254
2014
Q1
$9.33M Buy
138,960
+41,738
+43% +$2.8M 0.07% 297
2013
Q4
$6.25M Buy
97,222
+22,904
+31% +$1.47M 0.05% 355
2013
Q3
$4.76M Sell
74,318
-78,666
-51% -$5.04M 0.04% 383
2013
Q2
$4.74M Buy
+152,984
New +$4.74M 0.04% 417